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Abstract
Background: Regulation of protein output at the level of translation allows for a
rapid adaptation to dynamic changes to the cell’s requirements. This precise control
of gene expression is achieved by complex and interlinked biochemical processes
that modulate both the protein synthesis rate and stability of each individual mRNA.
A major factor coordinating this regulation is the Ccr4-Not complex. Despite playing
a role in most stages of the mRNA life cycle, no attempt has been made to take a
global integrated view of how the Ccr4-Not complex affects gene expression.
Results: This study has taken a comprehensive approach to investigate post-
transcriptional regulation mediated by the Ccr4-Not complex assessing steady-state
mRNA levels, ribosome position, mRNA stability, and protein production
transcriptome-wide. Depletion of the scaffold protein CNOT1 results in a global
upregulation of mRNA stability and the preferential stabilization of mRNAs enriched
for G/C-ending codons. We also uncover that mRNAs targeted to the ER for their
translation have reduced translational efficiency when CNOT1 is depleted, specifically
downstream of the signal sequence cleavage site. In contrast, translationally
upregulated mRNAs are normally localized in p-bodies, contain disorder-promoting
amino acids, and encode nuclear localized proteins. Finally, we identify ribosome
pause sites that are resolved or induced by the depletion of CNOT1.
Conclusions: We define the key mRNA features that determine how the human
Ccr4-Not complex differentially regulates mRNA fate and protein synthesis through a
mechanism linked to codon composition, amino acid usage, and mRNA localization.
Introduction
The Ccr4-Not complex is a large evolutionarily conserved multi-protein complex [1–
5], first described as a regulator of transcription [6–10]. It has since been shown to
have key regulatory roles extending well beyond transcription. It is a major complex
involved in regulating an mRNA throughout the entire mRNA life cycle including fa-
cilitating mRNA export [11], co-translational assembly of protein complexes [12],
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translational repression [13, 14], deadenylation, and mRNA destabilization [15–17]. In
humans, the Ccr4-Not complex has a molecular weight of ~ 1.2MDa [18]. The details
of how these different regulatory outputs are exerted and whether they are target-
specific is not fully understood. At the heart of the Ccr4-Not complex is the CNOT1
subunit, one of the roles of this subunit is to function as a scaffold to bring together
the complex subunits as well as many additional effector proteins contributing to the
diverse functions of the complex and thus acts as the central node for all the complex’s
functions [16, 18–22].
The Ccr4-Not complex has been shown to be delivered to mRNAs by multiple differ-
ent mechanisms including interaction with RNA-binding proteins that bind at the 3′
UTR [23–26], recruitment to miRNA-bound mRNAs by the miRISC complex [27] and
interaction directly of the Not5 subunit with the E-site of ribosomes with no tRNA
present at the A-site [28]. The most studied role of the Ccr4-Not complex is its in-
volvement in mRNA deadenylation—the removal of the poly(A) at the 3′ end of the
mRNA [29–32], which requires the activity of deadenylase subunits CNOT6/CNOT6L
and CNOT7/CNOT8 (known as Ccr4 and Caf1, respectively, in yeast) [16, 33]. This is
the primary event in the mRNA decay pathway followed by the removal of the 5′ cap
and subsequent degradation of the target mRNA [27, 34–37]. Deadenylation requires
the expulsion of the poly(A)-binding protein (PABP), which is thought to play an im-
portant role in the stability and translation of the mRNA [38].
The involvement of Ccr4-Not complex in the regulation of translation can be inde-
pendent of its deadenylase activities [2]. Indeed, deadenylation is not essential for trans-
lation repression of an mRNA by the Ccr4-Not complex in conjunction either with
RBPs [39, 40] or miRNAs [41–44]. Components of the Ccr4-Not complex are present
in polysomes and are thought to be involved in translational quality control in yeast
[45, 46]. In addition, the complex has been implicated as a player in the buffering of
gene expression (mechanisms that allow for compensatory regulation of mRNA levels
and translation in the maintenance of protein homeostasis) [47, 48].
The role of the open reading frame and its sequence composition has recently
emerged as equally important in the control of gene expression as that of the 5′ and 3′
UTRs, which have traditionally been seen as the regulatory hubs of the mRNA. More
specifically, codon usage has been highlighted as a key attribute linking translation
elongation to mRNA stability [49–53]. Interestingly, it is the nucleotide at the third
“wobble” position of the codon that can confer stabilizing / destabilizing effects on the
mRNA [54]. The precise mechanisms linking codon usage to mRNA abundance, trans-
lation elongation, and protein output are still not fully understood.
It is clear that the Ccr4-Not complex is a master regulator of mRNA fate. Despite
this, no effort has been made to uncouple the impact of the Ccr4-Not complex on
translation and mRNA abundance in shaping the final proteome on a system-wide
level. Also, there has not been a global investigation of the mRNA features that predis-
pose an mRNA to specific fate outcomes regulated by the Ccr4-Not complex. Here we
employed a number of high-throughput approaches—ribosome profiling, total RNA-
seq, mRNA half-life studies, and pulsed SILAC—in the context of depletion of the scaf-
fold protein CNOT1 to understand the complex’s activity in post-transcriptional con-
trol. Knockdown of CNOT1 also downregulates the synthesis of many other subunits
of the Ccr4-Not complex [19], which our results confirm (Additional File 1: Fig. S1A).
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We identify the features of mRNAs that determine the mechanism by which the Ccr4-
Not complex regulates mRNA fate. Specifically, we uncover the importance of the precise
codon composition of an mRNA in determining how the Ccr4-Not complex controls
mRNA stability. Moreover, we uncover that mRNA localization influences how the Ccr4-
Not complex impacts mRNA translation: mRNAs translated at the ER are translationally
downregulated after CNOT1 depletion, mRNAs that localize to p-bodies are translation-
ally upregulated and mRNAs encoding proteins that localize to the nucleus are regulated
at the level of translation but not stability by the Ccr4-Not complex. Lastly, we observe a
role for the Ccr4-Not complex in the regulation of ribosome pause sites.
Results
Global increase of mRNA stability following CNOT1 knockdown
The Ccr4-Not complex is believed to be a major regulator of mRNA stability through
its capacity to initiate mRNA decay by the deadenylase subunits, CNOT6/CNOT6L
and CNOT7/CNOT8 [15, 17, 37, 55, 56]. Recruitment of the Ccr4-Not complex is
thought to occur on all mRNAs at the end of the transcript lifecycle. It has been shown
for specific mRNAs that decay can be accelerated by the presence of particular RNA
motifs that are bound by RBPs which then interact with Ccr4-Not complex subunits
[57–62]. However, this has not been tested on a global scale. To fully understand the
distinct activities of the human Ccr4-Not complex in mRNA stability and translation, it
was necessary to dissociate its roles in transcription from mRNA stability [2, 63], as
both of these processes contribute to steady-state mRNA levels [64].
To determine how the Ccr4-Not complex impacts mRNA half-lives transcriptome-
wide, we sampled RNA at multiple time points after transcriptional inhibition using
triptolide [65] with and without CNOT1 depletion. Titration experiments were used to
determine the optimal concentration of triptolide (1 μM), which produces a good decay
curve for the short-lived MYC transcript without adversely affecting rRNA synthesis or
cell viability (Additional File 1: Fig. S1B-D). RNA was isolated at 0, 0.5, 1, 2, 4, 8, and
16 h after transcriptional inhibition and the CNOT1 knockdown (Additional File 1: Fig.
S1E) and RNA integrity (Additional File 1: Fig. S1F) were verified for each time point
before performing RNA-seq.
Examination of RNA levels at each time point relative to the 0 h time point shows a
global increase in mRNA stability following depletion of CNOT1 (Fig. 1A), clearly dem-
onstrating the complex’s central role in mRNA destabilization in human cells. An expo-
nential model of decay y ~ y0 e
−kt was fitted to the data, where k is the decay rate, y0 is
the mRNA level at time point 0, and yt is the mRNA level at time t. The mRNA half-
life was then calculated using the equation: t1/2 = ln(2)/k. The half-lives obtained in
control conditions for HEK293 cells showed a good correlation (r = 0.406) with pub-
lished half-lives from HEK293 cells obtained using a 4-thiouridine-based methodology
[66]. The median half-life in control conditions was 6.7 h, and there was an average
log2FC in half-life of 2.1 following CNOT1 depletion (Additional file 2: Table S1), dem-
onstrating there is a substantial global increase in mRNA stability. Using k-means clus-
tering the mRNAs can be grouped into three major clusters that are distinguishable by
their half-lives in the presence of CNOT1 and the extent of mRNA stabilization follow-
ing CNOT1 depletion (Fig. 1B, C). This demonstrates that the vast majority of mRNAs
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rely on the Ccr4-Not complex for mRNA turnover and there are some mRNAs
which are particularly susceptible to rapid destabilization by the Ccr4-Not complex.
The mRNA half-lives for specific mRNAs from each cluster (Additional File 1: Fig.
S2ABC) have been validated by qPCR with a different transcriptional inhibitor (fla-
vopiridol) and a different pool of siRNAs targeting CNOT1 (Additional File 1: Fig.
S2DEF). Overall, this shows that the Ccr4-Not complex is also the major regulator
of mRNA stability in human cells and for the first time quantifies this on a global
scale.
Fig. 1 G/C-ending codons drive mRNA destabilization by the Ccr4-Not complex. A Plot of RNA abundance
across multiple time points after inhibition of transcription with triptolide relative to the 0 h timepoint for
siControl and siCNOT1 treated samples (three biological replicates). B mRNAs grouped based on their
mRNA half-life in the presence and absence of CNOT1 using k-means clustering. C The mRNA half-lives
before and after CNOT1 depletion for the three major clusters of mRNAs determined in B. D The variable
influence (determined using gradient boosting) of mRNA sequence features on the log2FC mRNA half-life
after CNOT1 knockdown. E Log2FC mRNA half-life following CNOT1 depletion for mRNAs grouped by their
CDS length. F Correlation coefficient (Spearman’s rho) between the frequency of a given codon in an
mRNA and the log2FC mRNA half-life (siCNOT1 / siControl). Codons with an A/U at the 3rd nucleotide
position are colored in magenta and codons with a G/C at the 3rd nucleotide position are colored in cyan
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Moreover, gene ontology analysis conducted on all of the mRNAs ranked by their
log2FC half-life after CNOT1 knockdown showed a significant enrichment for only a
small number of terms, likely due to the fact that the Ccr4-Not complex is the major
regulator of the stability of most mRNAs. The terms that were significant related to
mitochondrion organization, cardiac/muscle development, and regulation of S/T kinase
activity (Additional File 1: Fig. S3A). These observation may point toward a mechanism
behind recent findings that the depletion of CNOT1 delays neurodevelopment [67] and
affects cardiac function [68], in that, these specific subsets of mRNAs are heavily reliant
on the Ccr4-Not complex for their stability.
G/C-ending codons drive Ccr4-Not-mediated mRNA destabilization
There are a number of attributes of the mRNA sequence that impact mRNA transla-
tion or stability including length, mRNA structure, and nucleotide composition within
different regions of the mRNA [69, 70]. To determine if any of these are potentially in-
volved in directing Ccr4-Not regulation of mRNA stability, the contribution of these
variables to the change in mRNA half-life following CNOT1 knockdown was evaluated
using gradient boosting [71]. First mRNA features were pre-filtered to remove highly
correlated variables (r > 0.7, Additional File 1: Fig. S3B). Analysis of the independent
variables showed that GC content and the length of the coding sequence (CDS) have
the greatest influence on the change in mRNA half-life (Fig. 1D). Grouping of mRNAs
by CDS length shows that shorter CDSes are associated with greater mRNA
stabilization following CNOT1 knockdown (Fig. 1E).
The defining aspect of CDS sequence composition is that it is organized into codon
triplets. CDS GC content is highly correlated with the GC content of the 3rd nucleotide
of the codon (Additional File 1: Fig. S3C) and components of the Ccr4-Not complex
have previously been implicated in codon-mediated regulation of mRNA translation in
yeast and zebrafish [16, 28, 72]. Therefore, we hypothesized that the observed differ-
ences in human cells may be driven by the codon usage within the mRNAs.
The codon stabilization coefficient is the correlation between the codon frequency
and the half-life of an mRNA [73]. Here we determined the correlation of the frequency
of a given codon with the log2FC in mRNA half-life after CNOT1 depletion. Strikingly,
this shows a strong split between the correlations of codon frequency of G/C-ending
(cyan) and A/U-ending (magenta) codons with the change in mRNA half-life (Fig. 1F).
In general, the greater the frequency of any given G/C-ending codon, the greater the
increase in half-life after CNOT1 knockdown (Fig. 1F). Together, this supports the
presence of G/C-ending codons is a primary driver of destabilization of an mRNA via
the Ccr4-Not complex.
Synonymous codons are those which differ in sequence but encode the same amino
acid. The distinct transcript pools present in proliferation and differentiation have been
shown to have opposing synonymous codon usage signatures [74–76]. mRNAs
enriched for A/U-ending codons are abundant in proliferation, whereas it is the
mRNAs that contain more G/C-ending codons that are abundant in differentiation [75,
76]. Having observed a clear distinction in how G/C-ending and A/U-ending codons
impact Ccr4-Not-mediated regulation of an mRNA’s stability (Fig. 1F), we sought to
understand if this was driven by synonymous codon usage differences. Hence, the
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correlation of log2FC half-life with codon frequency (Fig. 1F) was reordered by the
amino acid (Additional File 1: Fig.S3D). Unexpectedly, this highlights that while syn-
onymous codons are important for the distinction of mRNA stability regulation by the
Ccr4-Not complex, the amino acid itself further impacts the change in mRNA half-life
with CNOT1 knockdown (Additional File 1: Fig. S3D). For example, the G/C-ending
codons of some amino acids (e.g., Ala and Pro) correlate with an increase in mRNA
stability, but their synonymous A/U-ending codons show very minimal correlation with
stability changes (Additional File 1: Fig. S3D). A recent publication highlighted that
amino acid composition also affects mRNA stability [77] and here we expand on this
showing how amino acid differences contribute to the nature of the impact of G/C- or
A/U-ending codons on mRNA stability regulation by the Ccr4-Not complex.
Translational regulation by the Ccr4-Not complex
It is proposed that the regulation of mRNA stability is linked to translation elongation
[16, 52–54, 78, 79]. Recent structural data from yeast shows the Not5 subunit of the
Ccr4-Not complex can interact directly with the ribosome; this interaction occurs at
the ribosomal E-site when the A-site is unoccupied [28]. In addition to its described
role in mRNA destabilization, the Ccr4-Not complex has also been implicated in the
regulation of translational repression, which can occur independent of deadenylation
[39, 41, 80–82]. As of yet, no study has investigated the role of the human Ccr4-Not
complex at the level of translation on a system-wide level. Polysome gradients show
there is a global accumulation of polysomes following CNOT1 depletion (Fig. 2AB).
Whether the translational upregulation following CNOT1 depletion is a direct conse-
quence of the global increase in mRNA stability (Fig. 1A) or if the role of the Ccr4-Not
complex in the regulation of translation is distinct from how it controls mRNA stability
is unknown. Therefore, to assess the impact of the Ccr4-Not complex on translation of
individual mRNAs globally at codon resolution, ribosome profiling was conducted with
and without the depletion of CNOT1 (Fig. 2AB, Additional File 1: Fig.S4A-C). Ribo-
some profiling involves high-throughput sequencing of ribosome-protected fragments
(RPFs) [83, 84]. Quality control analysis of the RPF sequencing data showed the three
replicates contained an extremely low number of reads aligning to rRNA (Additional
File 1: Fig. S5A), were highly correlated (Additional File 1: Fig. S5B), had the expected
read length distribution (Additional File 1: Fig. S5C), the majority of reads aligned to
the CDS (Additional File 1: Fig. S5D), and showed a strong periodicity (Additional File
1: Fig. S5E). This demonstrates the ribosome profiling data is of very high quality and
provides a benchmark ribosome profiling dataset.
Translational efficiency (TE) is defined as the number of RPFs aligning to a given
CDS corrected for the mRNA’s abundance (determined by parallel total RNA-seq). Due
to differences in library preparation for RPFs and total RNA, differential expression
analysis using DESeq2 [85, 86] was conducted separately for each library type to obtain
a log2 fold change for RPF and RNA changes independently (Additional file 3: Table
S2). The change in translational efficiency was then determined by calculating log2FC
RPF – log2FC RNA. Our mRNA stability experiments demonstrated the global upregu-
lation of mRNA stability after CNOT1 depletion (Fig. 1A). There is also a global in-
crease in mRNA ribosome occupancy following CNOT1 depletion (Fig. 2B). Therefore,
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Fig. 2 (See legend on next page.)
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in this condition, and due to the nature of differential expression analysis, it is more ap-
propriate in this slightly unusual context to consider a negative log2FC as least upregu-
lated and the positive log2FC as most upregulated. Using the ribosome profiling, three
translationally regulated groups were defined (Fig. 2C): mRNAs with an increase in
RPFs complementary to the increased mRNA stability thus having no effective TE
change (yellow); mRNAs with a translation increase greater than the mRNA stability
increase (increased TE; red) and mRNAs with a translational increase lower than the
mRNA stability increase (decreased TE; blue). To validate the translational observations
for individual mRNAs within these groups (Fig. 2D–F & Additional File 1: Fig. S6), in-
dependent experiments (n = 2) were conducted without cycloheximide pre-treatment,
and RT-qPCR applied across all fractions of polysome gradients following treatment
with CNOT1 or control siRNA. Using this alternative approach, we show that mRNAs
with altered translational efficiency display the expected changes in polysome distribu-
tion (Fig. 2D, F, Additional File 1: Fig S6ABEF). In addition, mRNAs with correlated
changes at both the RPF level and RNA level (no effective TE change, yellow) show no
major changes in distribution across polysomes (Fig. 2E, Additional File 1: Fig. S6CD).
Together this confirms the ribosome profiling analysis correctly identifies mRNAs with
altered translation after CNOT1 knockdown.
Differentially translated mRNAs are functionally distinct
To determine if the functions of the proteins encoded by the mRNAs regulated at the
level of translation by the Ccr4-Not complex are different, gene set enrichment analysis
was conducted for the mRNAs ranked by the extent of the TE change with CNOT1 de-
pletion (Fig. 3A, Additional File 1: Fig. S7AB, Additional file 4: Table S3). This showed
a large number of gene ontology (GO) terms associated with decreased TE after
CNOT1 knockdown. This included GO terms related to development and morphogen-
esis, cell signalling pathways and structural components of the cell (Additional File 1:
Fig. S7A). These mRNAs are also associated with the endoplasmic reticulum (ER),
extracellular matrix (ECM), and plasma membrane (Fig. 3A). To investigate this in
more detail, cell lysates were separated into cytosolic and ER fractions (Fig. 3B) and the
RNA present in each fraction sequenced. K-means clustering has been used to define
mRNAs that predominantly localized to the cytosol or ER (Fig. 3C, Additional file 5:
(See figure on previous page.)
Fig. 2 Ribosome profiling identifies mRNAs regulated by the Ccr4-Not complex at the level of translation. A
Western blot confirms siRNA knockdown of CNOT1. Vinculin is used as a loading control. B Polysome gradient
profiles for samples treated with control or CNOT1-targeting siRNA. C There are groups of mRNAs with distinct
changes in ribosome occupancy and mRNA abundance when CNOT1 is depleted. Log2 fold change of RPFs
and RNA following CNOT1 depletion were determined using DESeq2 independently for each library type. Log2
translational efficiency (TE) was determined by log2FC RPF − log2FC RNA; a threshold of log2FC TE > 0.2 was
used to categorize mRNAs as having increased TE and a log2FC TE < − 0.2 for mRNAs with decreased TE. No
TE change was classified by a log2TE < 0.1 & > − 0.1. The table shows the number of mRNAs present in each
group. D–F qPCR along gradient fractions from an independent experiment with and without CNOT1
depletion (n = 1 shown, n = 2 is shown in Additional File 1: Fig. S6). D Validation of the increased TE after
CNOT1 depletion of POLB and HDHD3 from the group of mRNAs identified in (C) (red). In gray is the control
and in red is the CNOT1 siRNA treated. E Validation of the unchanged TE after CNOT1 depletion for DENR and
INTS7 from the group of mRNAs identified in (C) (yellow). In gray is the control and in yellow is the CNOT1
siRNA treated. F Validation of the decreased TE after CNOT1 depletion of GIT1 and POLR3E from the group of
mRNAs identified in (C, blue). In gray is the control and in blue is the CNOT1 siRNA treated
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Fig. 3 ER-targeted mRNAs are translationally downregulated following CNOT1 depletion. A All mRNAs were ordered
by the log2FC TE (siCNOT1/siControl) and gene set enrichment analysis conducted on the ranked list using the fgsea
R package for cellular components. BWestern blot confirming lysate fractionation into ER and cytosol with and
without the depletion of CNOT1. C k-means clustering of mRNAs based on their abundance (CPM) in the ER and
cytosolic fractions defines two groups of mRNAs based on their predominant localization. DmRNAs with decreased
TE when CNOT1 is depleted (identified in Fig. 2C) are enriched for targeting to the ER in control conditions. E Median
change in ribosome occupancy (normalized for mRNA abundance) assessed across the CDS for the groups of mRNAs
identified in Fig. 2C. F ER-targeted mRNAs globally decrease translationally efficiency following CNOT1 depletion. G
log2FC RNA in the cytosolic fraction between CNOT1 depleted and control conditions. H log2FC RNA in the ER
fraction between CNOT1 depleted and control conditions shows a reduction in mRNAs that are targeted to the ER in
control conditions localizing to the ER after CNOT1 depletion. I Displayed is the protein production change (siCNOT1/
siControl) for mRNAs predominantly localized to the cytosol or the ER. For (F–I), significance was determined using
the Kruskal-Wallis test. J Median change in ribosome occupancy (normalized for mRNA abundance) assessed across
the CDS for the mRNAs with decreased TE after CNOT1 depletion separated into two groups based on the predicted
presence of a signal sequence (determined using SignalP [91]). 157/899 mRNAs were predicted to contain a signal
sequence. K Predicted location of the signal peptidase cleavage site in the group of mRNAs with a predicted signal
sequence (determined using SignalP [91])
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Table S4); using these groups shows a greater proportion of mRNAs translationally
downregulated following CNOT1 depletion are indeed ER-targeted mRNAs in HEK293
cells (Fig. 3D) and the proteins encoded are localized at the ER and plasma membrane
(Additional File 1: Fig.S7CD, data from U2OS cells [87]).
In contrast, mRNAs encoding proteins associated with the mitochondria, splicing, or
the centrosome are translationally upregulated following CNOT1 depletion (Fig. 3A,
Additional File 1: Fig. S7A). Increased TE is also associated with proteins involved in
tRNA processing and modification as well as proteins having molecular functions in-
volved in DNA binding and repression of transcription (Additional File 1: Fig.S7AB).
Overall, this analysis suggests a role for the Ccr4-Not complex in the translational
regulation of functionally distinct and spatially localized groups of mRNAs.
Decreased ribosome occupancy after CNOT1 depletion occurs downstream of signal
sequences
Next, we examined the change in ribosome occupancy across the CDS. This showed
for mRNAs with increased translational efficiency the increased ribosome occupancy is
evenly distributed across the CDS (Fig. 3E). However, for translationally downregulated
mRNAs, ribosome occupancy ramps down sharply from the start codon throughout
the first ~ 10% of the CDS, followed by a large and even reduction across the final 75%
of the CDS (Fig. 3E). This suggests these mRNAs require the presence of the Ccr4-Not
complex for their efficient translation in the first section of their CDS in control condi-
tions. For example, this may be the result of the presence of regulatory sequences in
this region that control mRNA localization, such as the signal sequence recognized by
the signal recognition particle (SRP), which would conform with our observation about
the high abundance of ER-targeted mRNAs in this group (Fig. 3D). In addition, we see
a highly significant global reduction in the translational efficiency of ER-target mRNAs
following CNOT1 depletion (Fig. 3F), suggesting the Ccr4-Not complex specifically
plays a role in the regulation of mRNAs that localize to the ER to be translated.
To investigate this further, we fractionated cells into the ER and cytosol with and
without CNOT1 depletion (Fig. 3B) and sequenced the RNA from each fraction. Using
the classification of mRNAs predominantly localized in the ER or cytosol in control
conditions (Fig. 3C, Additional file 5: Table S4), we were able to assess how these
mRNAs change localization after CNOT1 knockdown. This clearly shows that ER-
targeted mRNAs have reduced levels specifically in the ER after CNOT1 knockdown
(Fig. 3G,H).
To confirm the impact of the altered mRNA localization and translational efficiency of
ER-targeted mRNAs on protein output, pulsed SILAC (stable isotope labelling by amino
acids in culture [88]) was conducted following CNOT1 depletion (Additional File 1: Fig.
S8A). A protein was only included in the analysis if it was detected in both the forward
and reverse labelling technical replicates (Additional File 1: Fig. S8) and in at least two of
the three biological repeats, this resulted in a group of 3495 proteins (Additional File 1:
Fig. S8C, Additional file 6: Table S5). The pulsed SILAC confirms that the reduced TE of
ER-target mRNAs is reflected in reduced protein synthesis (Fig. 3I).
Ribosome pausing can occur at the signal sequence [89] and if the mRNA is not cor-
rectly translocated to the ER for the continuation of its translation, this would result in
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lower ribosome occupation of the latter part of the CDS—as we observe. A very recent
publication observed disome populations at these signal sequences [90], and our data
suggests the involvement of the Ccr4-Not complex in the regulation of these pause
sites. To investigate this in more detail, SignalP [91] was used to select mRNAs with
predicted signal sequences. Separation of the positional data by the presence or absence
of predicted signal sequence shows sharper decline in ribosome occupancy for mRNAs
with a predicted signal sequence (Fig. 3J). The SRP cleavage site, on average, is posi-
tioned at around 4.75% of the length of the CDS (Fig. 3K). This position coincides with
the sharp decline in ribosome occupancy in the absence of CNOT1. This might suggest
that the Ccr4-Not complex accelerates the progression of the ribosome through this
site by either facilitating localization of the mRNA or the efficiency of cleavage. Thus,
in the absence of the complex, ribosome occupancy downstream of this position is sig-
nificantly diminished because the ribosomes cannot progress.
The impact of codons on Ccr4-Not complex mediated regulation of translational
efficiency
Having observed that an increase in mRNA half-life after CNOT1 depletion posi-
tively correlates with the frequency of G/C-ending codons (Fig. 1F), the correlation
of codon frequencies with the log2FC TE was next examined. This showed it is A/
U-ending codons that positively correlated with an increase in TE after CNOT1
knockdown (Additional File 1: Fig. S9A). However, of note is the extent of these
correlations which is not as strong as observed for mRNA half-life (Fig. 1F). Never-
theless, there is a strong distinction in the direction of the correlation based on
the 3rd nt of the codon as indicated in magenta/cyan (Additional File 1: Fig S9A).
To confirm the influence of this factor, the luciferase reporter system was utilized.
The Renilla luciferase CDS is naturally rich in A/U-ending codons (74.5%); hence,
the three G/C-ending codons (AUC, GUC & ACC) most negatively correlated with
the TE change were substituted into the Renilla sequence at the corresponding
synonymous codon positions. The translational efficiency was then determined
using the luciferase activity / luciferase RNA level determined by qPCR with firefly
luciferase used as a transfection control. This reporter clearly demonstrates that
conversion of A/U-ending codons in the Renilla CDS to synonymous G/C-ending
codons leads to a reduction in the extent of TE change after CNOT1 knockdown
(Additional File 1: Fig. S9B). This TE change is a consequence of both altered lu-
ciferase activity and RNA level.
mRNAs with AU-rich CDSes and 3′UTRs have been shown to be enriched in p-
bodies (sites of translational repression and mRNA storage) [92], and CNOT1 depletion
prevents p-body formation [19]. We are able to clearly show, using the previously pub-
lished HEK293 p-body transcriptome [93], that mRNAs translationally upregulated
after CNOT1 knockdown are most enriched in p-bodies in control conditions (Add-
itional File 1: Fig. S9C). The exact nature of p-bodies is not fully understood; they con-
tain components of the deadenylation and decapping machinery [19, 94–99] and the
role of deadenylation in their formation is debated [57, 92, 93, 100–104]. Our finding
suggests that these specific mRNAs might undergo targeted translational repression by
the Ccr4-Not complex followed by subsequent shuttling to p-bodies for storage.
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How regulation of mRNA translation and/or stability by the Ccr4-Not complex impacts
protein output
As we had determined that there is a global upregulation of both mRNA stability and
translation following depletion of CNOT1, we next sought to understand the role of
the Ccr4-Not complex in translation both alongside and independent of its role regu-
lating mRNA stability. To dissect how the Ccr4-Not complex regulates mRNA transla-
tion compared to its control of stability, mRNAs were grouped based on the change in
their translational efficiency (as assessed by ribosome profiling) and change in mRNA
half-life (determined by triptolide inhibition) following CNOT1 depletion (Fig. 4A).
This generates six groups of mRNAs classified first by whether there is decreased TE,
no TE change, or increased TE (blue, yellow, and red, respectively, as in Fig. 2C), and
second by a small change in mRNA half-life or a large increase in mRNA half-life (dark,
light, respectively) when CNOT1 is depleted (Fig. 4A; Additional File 1: Fig. S10A).
Next the aim was to investigate how the observed translation and stability changes
impact protein output by use of the pulsed SILAC data (Additional File 1: Fig. S8). The
Ccr4-Not complex has a global role in the regulation of both mRNA stability and trans-
lation, and this is the first time the influence of this complex on protein output has
been assessed. Analysis of protein-level changes in the differentially regulated groups of
mRNAs (Fig. 4A). This shows that increased stability after CNOT1 knockdown results
in increased protein synthesis compared to mRNAs with a minimal change in stability
(light v dark colors, Fig. 4B). In addition, increased TE after CNOT1 knockdown is as-
sociated with increased protein synthesis (red v yellow, Fig. 4B) and decreased TE asso-
ciated with decreased protein synthesis in comparison to mRNAs with a similar mRNA
stability change but no change in TE (blue v yellow, Fig. 4B).
CDS composition differentiates how the Ccr4-Not complex regulates of mRNA translation
vs stability
The Ccr4-Not complex has been shown to have roles in the regulation of both mRNA
stability and translation [13–17, 19, 105]. To identify mRNA features that specifically
influence how the complex regulates translation as opposed to stability, the importance
of these variables in determining the mRNA group assignment (classification as in Fig.
4A) was evaluated using gradient boosting [71]. The feature analysis again points to-
ward the CDS as a major driver for differential regulation of mRNA fate mediated via
the Ccr4-Not complex, with the four most influential features pertaining to the CDS
(Fig. 4C). Closer analysis of the top influential features shows it is shorter mRNAs that
are most highly upregulated in terms of stability (Fig. 4D). The CDS GC content
strongly distinguishes mRNAs with a large increase in half-life following CNOT1 deple-
tion, from those with a lesser increase in half-life (Fig. 4E). Additionally, the AG con-
tent of the CDS distinguishes the translational changes between the groups of mRNAs
with small increase in half-life (blue/yellow/red, Fig. 4F). mRNAs with increased trans-
lation are more AG-rich in the CDS than mRNAs with decreased translation (Fig. 4F).
In terms of 3′UTR features, the 3′UTR A content and length were the most influen-
tial for group classification (Fig. 4C). mRNAs with shorter 3′UTRs have increased TE
with CNOT1 knockdown and mRNAs with decreased TE have longer 3′UTRs, with no
influence of stability (Additional File 1: Fig. S10B). This suggests the translationally
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downregulated mRNAs may be more highly regulated as longer 3′UTRs means in-
creased potential for the presence of regulatory sequences. Also, mRNAs with increased
TE have a higher 3′UTR A content compared to the mRNAs with decreased TE that
have a comparable half-life change (Additional File 1: Fig. S10C).
Fig. 4 mRNA features that distinguish the role of the Ccr4-Not complex in the regulation of mRNA translation v
stability. A Data shows the log2FC in mRNA half-life after CNOT1 depletion (x-axis) compared to the log2FC translational
efficiency (y-axis). mRNAs are first classified based on their mRNA stability change—a low log2FC mRNA half-life (dark
colors) or a high log2FC mRNA half-life (light colors) and second by their TE change—increased TE (red), no TE change
(yellow), or decreased TE (blue). B Pulsed SILAC data for three biological repeats conducted with forward and reverse
labelling (Additional File 1: Fig. S8A-C). Displayed is the protein production change (siCNOT1/siControl) for the proteins
that were detected in at least two biological repeats for the groups of mRNAs classified in (A). Non-significant
comparisons are indicated, and all statistical comparisons are shown in Additional File 9: Fig. S1A. C The influence of
mRNA sequence features on the classification of mRNAs into groups based how the Ccr4-Not complex differentially
regulates their stability and/or translation (Fig. 4A) was determined by gradient boosting. D–F The presence of the top
three features identified in (D) in the differentially regulated groups of mRNAs. D CDS length, E CDS G/C nucleotide
content, and F CDS A/G nucleotide content. For clarity, non-significant comparisons are indicated, and all statistical
comparisons are shown in Additional File 9: Fig. S1BCD
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Overall, this analysis highlights a significant role for the CDS in coordinating Ccr4-
Not complex function and further dissects the role of the complex in the regulation of
translation compared to its roles in mRNA stability.
Nuclear proteins enriched for disorder-promoting AAs are translationally upregulated
We have shown that the frequency of G/C-ending codons is associated with mRNA
destabilization by the Ccr4-Not complex (Fig. 1F), and feature analysis highlights the
CDS composition as a distinguishing factor between differentially regulated groups of
mRNAs (Fig. 4C–F). Analysis of average synonymous usage of codons for each of the
groups of mRNAs revealed a strong distinction in the use of synonymous codons be-
tween mRNAs with a small and large increase in stability (Fig. 5A), in agreement with
the earlier correlation data based on codon frequency (Fig. 1F). However, there are no
additional major differences in synonymous codon usage preferences when dissecting
this further to the level of altered translation (Fig. 5A). This suggests the synonymous
codon usage is involved in how the Ccr4-Not complex regulates mRNA stability but is
not a major determinant of its independent role in translation. Further investigation of
how codon frequencies ultimately impact protein synthesis demonstrates that although
the 3rd nucleotide preference of codons contributes to mRNA stability and translational
efficiency regulated by the Ccr4-Not complex (Fig. 1F & Additional File 1: Fig. S9A),
their frequency does not strongly correlate with protein production changes after
CNOT1 depletion (Additional File 1: Fig.S9D).
We therefore examined the amino acid frequency in the differentially regulated
groups of mRNAs. This shows, in addition to the synonymous codon usage, there is
also a bias in the amino acid composition of these mRNAs (Fig. 5B). mRNAs with in-
creased translation are enriched for polar/charged amino acids (AAs) and are depleted
of non-polar amino acids (Fig. 5B). mRNAs with decreased translation show no prefer-
ence for these same charged/polar amino acids (Fig. 5B). This suggests that it is a com-
bination of codon and amino acid usage that influence how the Ccr4-Not complex
regulates mRNA stability and translation and ultimately protein output.
Polar/charged AAs are often classified as disorder-promoting AAs in terms of their
role in protein structure [106, 107]. Therefore, we examined the presence of these
disorder-promoting AAs in the differentially regulated groups of mRNAs, which clearly
showed they are enriched in the mRNAs with increase TE but minimal change in sta-
bility (Fig. 5C). AAs are important for protein function and can influence ribosome de-
coding speeds [78, 108, 109]. To understand the role of the disordered AAs in this
group of mRNAs, we assessed the localization of the disordered AAs along the CDS.
This showed the disordered AAs in the translationally upregulated group of mRNAs
are enriched across the CDS and are particularly enriched at the 3′ end of the CDS
compared to mRNAs with no effective TE change (Fig. 5D). Analysis of the protein
class [110] of the mRNAs with increased TE showed an enrichment for transcription
factors (TFs), specifically C2H2 zinc-finger TFs (Fig. 5E) and protein localization data
confirms these translationally upregulated mRNAs encode proteins that are nuclear/
chromatin localized (Additional File 1: Fig.S10D, data from [87]).
Unexpectedly, these zinc-finger protein mRNAs also have relatively short half-lives in
control conditions, but do not show any change in mRNA stability with CNOT1
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depletion (Additional File 1: Fig. S10E). This is interesting because the mRNA turnover
of this group of mRNAs appears completely independent of the Ccr4-Not complex,
suggesting they are regulated by a distinct decay pathway and the Ccr4-Not complex is
only involved in their translational regulation, perhaps linked to their specialized role
in transcriptional control.
Fig. 5 Nuclear proteins enriched for disorder-promoting AAs are translationally upregulated. A Heatmap
represents the synonymous codon usage of each codon that encodes a given amino acid and a column z-
score has been applied to compare the codon preference between the groups of mRNAs. The colored bar
at the top indicates the nucleotide present at the third position in the codon. B Heatmap shows the
average frequency of each amino acid per mRNA and a column z-score has been applied. The colored bar
at the top classifies the amino acids by their side chain type. C The percentage of amino acids encoded by
the mRNAs that promote disorder in protein structure [106, 107]. Key significant comparisons are shown,
and all statistical comparisons are presented in Additional File 9: Fig. S2A. D The localization of disorder-
promoting amino acids across the CDS for the groups of mRNAs with minimal changes in mRNA stability. E
Protein class enrichment analysis (using PANTHER [110]) shows that the mRNAs with increased TE but
minimal increase in stability are enriched for transcription factors, specifically C2H2 zinc-finger proteins
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Ribosome pause sites regulated by the Ccr4-Not complex
The number of ribosomes on the mRNA at a point in time has often been used as an
indicator of protein output—the more ribosomes on the mRNA the more translated
the mRNA and hence the more protein produced. However, this is not always the case,
both elongation and initiation rates dictate the overall ribosome occupancy observed at
a single point in time. For example, decreased ribosome occupancy could be an indica-
tor of removal of an elongation block resulting in increased elongation speed and there-
fore fewer ribosomes on the mRNA. Conversely, increased ribosome occupancy could
be a result of either resolving a block at initiation of translation or decreased elongation
speed which would result in slower run-off of ribosomes.
In yeast, it has been suggested that the Ccr4-Not complex is linked to ribosome paus-
ing [12, 28]. Our ribosome profiling data with and without depletion of CNOT1 in
HEK293 cells was utilized to examine this further in human cells. First, a pause site in
each condition was defined as a position with a RPF peak height ten times greater than
the average RPF peak on the mRNA. Second, these pause sites were then classified as
either “sustained” meaning they are present but unaltered with CNOT1 knockdown;
“resolved” in that the reduction in RPF peak height is ten times greater than the aver-
age delta decrease across the mRNA or “induced” in that the increase in RPF peak
height is ten times greater than the average delta increase (Fig. 6A, Additional file 7:
Table S6). Figure 6 B, C, and D show ribosome P-site occupancy for example mRNAs
after normalization for mRNA abundance in control and CNOT1 knockdown condi-
tions that contain the distinct pause site types (ribosome P- site shown and determined
by read offset of 12 nt: Additional File 1: Fig. S11AB). It is possible for a specific mRNA
to have pause sites meeting more than one of these criteria, Fig. 6A indicates the num-
ber of mRNAs containing combinations of these pause types, and the mRNAs distinctly
with one type are used in downstream analysis to characterize these pause site types in
more detail.
It has been proposed that the Ccr4-Not complex can sense paused ribosomes and
trigger mRNA decay [28], and examination of the change in mRNA half-life with
CNOT1 knockdown of the distinct pause type groups shows mRNAs with sustained
and induced pauses undergo greater stabilization following CNOT1 depletion (Fig. 6E).
This would fit with a model whereby the Ccr4-Not complex is involved in the sensing
of stalled ribosomes and their resolution via decay mechanisms in that in the absence
of CNOT1 the pauses are sustained or become pronounced.
In contrast, the mRNAs with pauses resolved by CNOT1 knockdown do not show an
increase in mRNA half-life. To assess whether these are genuine sites of stalled ribo-
somes, the unique combination of pulsed SILAC and ribosome profiling data was used.
We observe that the ratio between protein production and ribosome occupancy in-
creases on mRNAs with resolved pause sites after CNOT1 depletion (Fig. 6F). This
demonstrates that CNOT1 knockdown resolves ribosome pauses on these messages
leading to altered translation and protein synthesis.
Next, we examined whether there are specific sequence motifs associated with these
Ccr4-Not complex regulated pause sites. Figure 6 G, H, and I show the amino acid se-
quence motif at the E, P, and A-site and the 3 codons up- and downstream for each of
the pause site types (created using Seq2Logo [111]). This shows a strong enrichment
for charged amino acids, particularly glutamate, being encoded at the A-site position of
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resolved and sustained pauses (Fig. 6G, H). This suggests this is a specific motif for
ribosome pausing in control conditions, but there may be additional factors that deter-
mine precisely how the Ccr4-Not complex acts upon the pause site. A sequence motif
at induced pause sites is not so pronounced but has an enrichment for aspartate at the
ribosome E-site (Fig. 6I).
Previously, ribosome pausing on two specific proteasome component mRNAs in yeast
has been shown to be regulated by Not1 to facilitate co-translational assembly [12].
Fig. 6 Ribosome pause sites regulated by the Ccr4-Not complex. A Venn diagram indicates the number of
mRNAs that contain pause sites sustained, induced, or resolved following the depletion of CNOT1. B–D
Examples of individual mRNAs with different Ccr4-Not regulated ribosome pause types. B Pause resolved in
the absence of CNOT1. C Paused sustained in the presence and absence of CNOT1. D Paused induced by
CNOT1 knockdown. Plots show RPF coverage normalized for mRNA abundance (TPM). E The change in
mRNA half-life after CNOT1 knockdown for the groups of mRNAs with different pause types identified in
(A). F mRNAs with resolved pause sites in the absence of CNOT1 shown an increase in protein production
relative to the ribosome occupancy on the mRNA when CNOT1 is depleted. G–I Amino acid sequence
motifs at the E, P, A sites of paused ribosomes and three codons upstream and downstream generated
using Seq2Logo [111], shown for resolved pauses (G), sustained pauses (H), and induced paused (I)
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Although there is still more to be elucidated about the precise mechanisms at play, this
study now provides evidence for the role of the Ccr4-Not complex in the regulation of
ribosome pausing in human cells and this regulation appears to be more widespread.
Discussion
Numerous mechanisms for mRNA specific recruitment of Ccr4-Not complex exist,
whereby sequence motifs, predominantly in the 3′UTR, are recognized by sequence
specific RNA-binding proteins or microRNAs, resulting in the delivery of the Ccr4-Not
complex to the mRNA [61, 82, 112–115]. Importantly the Ccr4-Not complex has been
shown to be able to exert both translational inhibition and mRNA destabilization and
that these effects can occur separately [39, 41].
The CNOT1 subunit of the Ccr4-Not complex functions as a scaffold protein bring-
ing into proximity the core subunits, and regulatory proteins to coordinate the varied
roles of the complex [5, 116, 117]. CNOT1 also interacts with proteins such as TNRC6
that recruit the Ccr4-Not complex to the mRNA during miRNA-mediated repression
[80, 112]. Here we have depleted CNOT1 to examine the global effects upon mRNA
stability (Fig. 1, Additional File 1: Fig. S1,2), the translational status of the mRNAs (Fig.
2, Additional File 1: Fig. S4,5), and protein production (Fig. 4B, Additional File 1: Fig.
S8). This is the first such comprehensive investigation of this multifunctional protein
complex and provides a benchmark dataset for translational studies. We demonstrate
for the first time in human cells how the Ccr4-Not complex differentially regulates co-
horts of mRNAs and how translational repression is distinct from how the complex
regulates mRNA deadenylation and stability.
Codon usage, and more recently amino acid usage, has been associated with differ-
ences in mRNA stability in control conditions in multiple organisms [51, 52, 77, 79,
118–120]. An example is reporter studies in yeast that have shown that substitution of
optimal codons with synonymous non-optimal (generally A/U-ending) ones reduces
mRNA stability [52]. Recent studies in human cells have also found A/U-ending codons
to be destabilizing [79, 120], whereas another study has found G/C-ending codons to
be destabilizing [92]. It is of note that this differential regulation may change with cellu-
lar context as it has been demonstrated that mRNAs preferentially involved in prolifer-
ation (enriched for A/U-ending codons) and differentiation (enriched for G/C-ending
codons) have distinct codon usage and the tRNA pool available is altered to reflect this
[75, 76, 121]. Thus, the inconsistency in whether it is the A/U-ending or G/C-ending
synonymous codons that are classified as destabilizing in the literature could be ex-
plained by conditional differences.
Moreover, there is minimal understanding of the proteins involved in coordinating
the response to codon usage. Previous research in yeast and zebrafish has implicated
subunits of the Ccr4-Not complex in codon-mediated regulation of mRNA stability
[16, 28, 72]. We show that knockdown of CNOT1 preferentially stabilizes mRNAs
enriched in G/C-ending codons (Fig. 1D, F, Fig. 5A) and thus show the central role of
the Ccr4-Not complex in the link between mRNA stability and codon usage in human
cells. Studies of the translatome and mRNA half-life are not often complemented with
protein-level data. Unexpectedly, we show that while large changes in mRNA stability
attributable to codon composition of the CDS are observed (Figs. 1F and 5A), these
correlations are not apparent in the pulsed SILAC data (Additional File 1: Fig S9D).
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Gene ontology analysis highlighted that increased mRNA half-life after CNOT1
knockdown is associated with an enrichment for biological processes relating to cardiac
septum and muscle organ development (Additional File 1: Fig. S3A), which is particu-
larly interesting given that recent publications demonstrate the importance of CNOT1
for cardiac development [68] and neurodevelopment [122]. Decreased translational effi-
ciency in the absence of CNOT1 is observed for mRNAs encoding proteins involved in
extracellular structure organization that preferentially localize to the ER and plasma
membrane (Fig. 3, Additional File 1: Fig. S7). We also find that the reduced ribosome
occupancy among this group of mRNAs following CNOT1 depletion occurs down-
stream of the signal sequence cleavage site (Fig. 3J, K) and reduced localization of
mRNAs to the ER after CNOT1 depletion (Fig. 3H). An intriguing hypothesis would be
that one of the translational control mechanisms mediated by the Ccr4-Not complex is
coordination of subcellular localization of mRNA.
In addition, our data shows a role for the Ccr4-Not complex in the translational
repression of mRNAs that are localized to p-bodies (Additional File 1: Fig. S9C). It
will be interesting to investigate in the future whether this is due to an indirect
role of CNOT1 in p-body formation [19] or if the Ccr4-Not complex is also in-
volved in mediating repression that occurs within these granules. The mRNAs
translationally upregulated following CNOT1 depletion encode transcription fac-
tors/nuclear proteins (Fig. 5E, Additional File 1: Fig S10D), in agreement with p-
body studies [92, 93]. They are also enriched for amino acids associated with disor-
dered regions in the proteins (Fig. 5C), intrinsically disordered regions have been
suggested to be the regions of transcription factors that interact with the promoter
region [123, 124]. Also, the tertiary structure of zinc-finger domains has been
shown to be able to act as a nuclear localization sequence [125, 126], so perhaps
the distinct amino acid composition of this group of mRNAs pertains to the
localization and protein function.
Finally, we identify groups of mRNAs on which ribosome pausing occurs in a
CNOT1-dependent manner (Fig. 6A). These pauses impact how the Ccr4-Not complex
regulates mRNA half-life (Fig. 6E) and protein synthesis (Fig. 6F). There is an enrich-
ment for charged amino acids at the A-site of paused ribosomes in the presence of
CNOT1 (Fig. 6G, H). Whether there are additional proteins and/or sequence motifs
that determine precisely how the Ccr4-Not complex regulates the fate of mRNAs with
paused ribosomes could be investigated in the future.
Conclusions
Here we have demonstrated that the CDS composition of an mRNA is important for
the regulation of its fate by the Ccr4-Not complex in terms of codon usage and CDS
length. In this cellular context, G/C-ending codons mediate the destabilization of an
mRNA by the Ccr4-Not complex. We also discover a novel role for the Ccr4-Not com-
plex in the regulation of the localization of mRNAs to the ER for their translation.
Moreover, mRNAs encoding proteins that localize to the nucleus are regulated at the
level of translation by the Ccr4-Not complex and are sequestered in p-bodies in control
conditions. Overall, we show that the Ccr4-Not complex is a control hub that governs
multiple mechanisms to precisely regulate the fate of each mRNA.
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Experimental methods
Cell culture
HEK293 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 1% L-glut and 10% FBS. The HEK293 cell line was not validated and cells
were routinely tested for mycoplasma.
siRNA treatment
Control siRNA (#3 Dharmacon) or CNOT1 siRNA (Ambion no. S22844) was trans-
fected using DharmaFECT 1 (2:1 ratio of siRNA to DharmaFECT 1) to a final concen-
tration of 30 nM and cells harvested after 48 h. Due to CNOT1 siRNA treatment
causing slowed cell growth, cells for CNOT1 siRNA treatment were plated at 10% in-
creased density to obtain the same cell numbers as the control samples at the time of
harvesting. For experiments in Additional File 1: Fig. S2DEF & Fig. S9B, an additional
siRNA pool targeting CNOT1 was used (Horizon Discovery 015369-01).
Antibodies
For western blot, the antibodies used were as follows: CNOT1 (ATLAS HPA Rabbit
046577, 1:500), vinculin (abcam mouse ab18058, 1in 10,000), GAPDH (CST 5174, 1:
1000), Calnexin (CST 2679, 1:1000), rabbit secondary antibody (LI-COR Biosciences
926-32213, 1:10,000), mouse secondary antibody (LI-COR Biosciences 926-68072, 1:
10,000). Uncropped western blots are presented in Additional File 3.
Ribosome profiling
Ribosome profiling was conducted as previously described in Wilczynska et al.. In par-
allel to these control experiments, ribosome profiling was conducted for samples trans-
fected with CNOT1-targeting siRNA for 48 h. Three biological replicates were
conducted.
RT-qPCR from gradient fractions
For validation experiments, media was changed on a 15-cm plate of HEK293 cells 1.5 h
prior to harvesting. Cells were then scraped in ice-cold PBS, spun down, and resus-
pended in lysis buffer containing cycloheximide. Then, 300 μl lysate was loaded on to a
10–50% sucrose gradient then spun at 38,000 rpm for 2 h at 4 °C. Gradient fractions
were collected into 3 ml 7M GuHCl, 8 μl glycogen, and 4ml ethanol added and then
precipitated for > 24 h at − 20 °C. The collected gradient fractions were pelleted at
4000 rpm for 1 h at 4 °C. The supernatant was removed, and the pellets resuspended in
400 μl RNase-free water. The samples were then transferred to 1.5-ml Eppendorfs, 2 μl
glycogen, 40 μl 3 M NaOAc pH 5.2, and 1ml 100% ethanol added. These were precipi-
tated overnight at − 20 °C. Samples were then pelleted at 13,000 rpm 4 °C for 40 min,
washed with 500 μl 75% ethanol, air dried, and resuspended in 30 μl RNase-free water.
To check the RNA integrity, equal volumes (3 μl) of each fraction along the gradient
were ran on a 1% agarose gel.
RT-PCR was conducted on equal volumes (3 μl) of each fraction using SuperScript
III (Invitrogen 18080085). qPCR was then conducted using SYBR Green master mix
(Applied Biosystems 4385618) on an Applied BioSystems QuantStudio 5 machine. For
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qPCR along the gradient fractions, the proportion of the mRNA present in fraction was
plotted. All qPCR primers used are included in Additional file 8: Table S7.
Cell viability
Cells were grown in 12-well plates and treated with a range of triptolide concentrations.
Then, 100 μl trypsin was added per well and 200 μl media added to quench this. Ten
microliters of cells was then mixed with 10 μl tryphan blue, and cells negative and posi-
tive for tryphan blue were counted using a hemocytometer.
Transcriptional inhibition experiments
For the transcriptional inhibition experiments to determine mRNA half-lives, cells were
plated in 12-well plates and transfected with control or CNOT1-targeting siRNA for
48 h. The medium was changed 1 h prior to treatment with 1 μM triptolide (abcam:
ab120720). At a range of time points (0, 0.5, 1, 2, 4, 8, and 16 h) post-triptolide
addition, cells were washed with PBS and lysed directly in 1ml of Trizol for RNA sam-
ples or 150 μl 1.5× SDS sample buffer for protein samples. Three biological replicates
were conducted. The RNA was extracted with Trizol and acid-phenol chloroform.
Three micrograms of RNA was then poly(A) selected (Lexogen 039.100). Four nano-
grams of poly(A) selected RNA was used as input into the CORALL Total RNA-Seq li-
brary prep kit (Lexogen 096.96) with 11 PCR cycles used. For qPCR validations
(Additional File 1: Fig S2DEF), 1 μM flavopiridol was used and 100 ng/μl oligodT used
in the RT reaction.
Cytoplasmic/ER fractionation
Fractionation of cytoplasmic and ER material was performed by sequential detergent
extraction, as previously reported (Reid, JBC, 2012). An isotonic buffer (20 mM Tris pH
7.4, 150 mM NaCl, 5 mM MgCl2) was supplemented with 1 mM DTT, 1× cOmplete
EDTA-free protease inhibitor (Roche). For sequential lysis, it was further supplemented
with 0.015% digitonin (cytosolic buffer), or 0.004% digitonin (wash buffer), or 2% n-
Dodecyl β-D-maltoside (ER buffer). Then, 80 U/ml of Ribolock RNase Inhibitor
(Thermo Scientific) was added to each final buffer. Two thirds of each sample was
processed for RNA extraction with Trizol LS, and 5× SDS sample buffer added to the
remaining lysate for western blotting.
Prior to library preparation, ERCC spike-ins (Invitrogen) were added proportionally
between the cytosolic and ER fraction in each condition. In total, 900 ng of RNA was
rRNA depleted with the RiboCop rRNA Depletion Kit HMR V2 (Lexogen) and library
preparation performed with the CORALL Total RNA-Seq Library Prep Kit (Lexogen
096.96). Sequencing was performed on a NextSeq 550 system (Illumina).
Pulsed SILAC (stable isotope labelling by amino acids in cell culture)
These experiments were conducted as described in Wilczynska et al. (repeat 1—for-
ward and reverse—is the data used in Wilczynska et al.). In brief, HEK293 cells were
cultured and siRNA treated for 30 h. This media was then replaced with DMEM that
does not contain arginine or lysine (Life Technologies). For the medium-heavy isotope-
containing medium, a supplement of [13C6] L-arginine (Arg-6) and [2H4] L-lysine
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(Lys-4) was added (Cambridge Isotope Laboratories). For the heavy isotope-containing
medium, [13C6][15 N4] L-arginine (Arg-10) and [13C6][15 N2] L-lysine (Lys-8) were
added (Cambridge Isotope Laboratories). Both forward (heavy CNOT1 siRNA/
medium-heavy control siRNA) and reverse (medium-heavy CNOT1 siRNA/heavy
CNOT1 siRNA) replicates were conducted for each biological repeat. After 14 h, cells
were lysed in SDS-free RIPA buffer, pooled in a 1:1 ratio, reduced with DTT and alky-
lated with iodoacetamide. The samples were then trypsin digested and fractionated
using reverse phase chromatography. For the exact details of the analysis of the samples
by mass spectrometry and the data analysis with MaxQuant software [127], see Wilc-
zynska et al 2019. A protein was retained for downstream analysis if it was detected in
the forward and reverse replicate for a given biological repeat, and if detected in at least
two of the three biological repeats.
Luciferase reporter experiments
Twenty-four hours after siRNA transfection in 12-well plates, cells were transfected
with 40 ng pRL and 160 ng pGL3 intron as a transfection control (Meijer NAR 2019)
using 0.6 μl GeneJammer (Agilent). The Renilla construct (pRL) was either the original
sequence or a sequence with all the AUU/GUU/ACU codons converted to their syn-
onymous codons (AUC/GUC/ACC). After another 24 h, samples for detection of lucif-
erase activity were washed twice with PBS and lysed in 1× passive lysis buffer, and 10 μl
lysate used for luciferase detection using the Dual Luciferase Reporter Assay System
(Promega). Samples for RNA were harvested in 1 ml Trizol. Relative luciferase activity
was determined by the ratio between Renilla and Firefly luciferase and the relative lucif-
erase RNA levels determined by qPCR. The translational efficiency of Renilla was then
determined by luciferase activity / RNA level.
Data analysis methods
mRNA half-life experiment RNA sequencing data processing
Cutadapt [128] was used to remove adapters. cd-hit-dup [129] was used to deduplicate
the reads based on the 12-nt-long UMIs. The remaining reads were aligned to the gen-
ome using STAR [130] and a gtf file filtered to contain the most abundant transcript
per gene. To obtain the read counts featureCounts [131] was used with the gtf file fil-
tered for the most abundant transcript per gene. The read counts were first normalized
for the library size. As the libraries are prepared based on equal ng of material, the read
counts are normalized back to the nanodrop concentrations of the RNA that was ob-
tained from equal cell numbers. For each condition, the data was then normalized rela-
tive to the 0 h time point to allow for comparison between mRNAs and conditions.
Modelling mRNA decay rate
To be able to use the three replicates together in the decay modelling, for each replicate
the values for each mRNA across the time points were normalized to the 0 h time point
(set at 100). The simple model for mRNA decay is that it follows the exponential decay
function: y ~ y0e
−kt. Where y0 is the steady-state mRNA level, k is the decay constant
and t is time. Outliers were first identified based on the methodology described in
[132]. The nlrob function (R package: robustbase) was used to fit a robust nonlinear
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model to the data with an adapted from of the NLS.expoDecay function (R package:
aomisc) to provide start parameters for the model fit. To next identify possible outliers,
the weighted residual was calculated: weighted residual = absolute (observed − ex-
pected)/expected. The maximum proportion of outliers was set to 20% to ensure nat-
ural biological variation was not mistaken for an outlier. The robust standard deviation
of residuals (RSDR [132];) was then calculated by ranking the residuals in terms of ab-
solute value and taking the value at the 68.27 percentile and multiplying this value by
N/(N − K), where N is the number of values and K is the number of parameters being
modelled. The significance level for outlier removal is αi = Q(N − (i − 1))/N, where N
is the number of values in the data and i is the ith value in the ordered list of residuals.
Q was set to 5% (0.05) and this means that there is a 5% chance of falsely discovering a
significant outlier. The t-score in this case in then calculated by: t-score = residuali/
RSDR [132]. The pt function (R package: stats) is then used to obtain the two-tailed p
value of the t-score. If this p value is less than αi, then this value is a significant outlier.
Once significant outliers had been removed, the modelling was conducted in R using
the nls function from the stats package. To ensure appropriate starting parameters were
used in the modelling a self-starting function was used—NLS.expoDecay() part of the
aomisc R package. The half-lives were then calculated from the decay rate using the
equation: t1/2 = ln(2)/k.
Assessment of feature influence
To assess which mRNA features contribute to differential regulation of mRNA fate by
the Ccr4-Not complex, a supervised learning approach of gradient boosting (gbm R
package) was used (Figs. 1D and 4C). Only one of highly correlated features (r > 0.7)
were retained for the analysis (Additional File 1: Fig. S3B). For Fig. 1D, a Gaussian dis-
tribution was assumed and for Fig. 4C a multinomial distribution. The parameters used
were as follows: n.trees = 200, interaction.depth = 6, shrinkage = 0.005, cv.folds = 10.
Ribosome profiling—small RNA alignment and counts
For the small RNA sequencing data (ribosome protected fragments: RPFs), Cutadapt
[128] was used to remove the adapter sequence and the reads were deduplicated based
on the 8-nt unique molecular indexes (UMIs—4 nt either end of the read) using cd-hit-
dup [129]. Cutadapt [111] was then used to remove UMIs and to select read lengths 25
to 35 nt (the expected size range of the RPFs). The reads were first aligned to a fasta file
of rRNA sequences, to remove contaminant rRNA fragments by alignment with bowtie
[133]. The reads were then mapped with bowtie to the hg38 gencode version 28 [134])
protein coding transcriptome that had been filtered for the most abundant transcript
per gene as determined from the control total RNA-seq data.
To get the number of RPFs per gene and the exact position of the RPFs along the
mRNA, a python script from the RiboCount part of the RiboPlot package (https://
pythonhosted.org/riboplot/) was adapted. This was first conducted for each read length
to determine the frame, periodicity, and P-site offset for each read length. It was deter-
mined that read lengths 27 to 31 showed strong RPF characteristics, thus these read
lengths were selected for downstream analysis. E, P, and A-site offset were determined
to be 9 nt, 12 nt, and 15 nt from the read start respectively (see Additional File 1: Fig.
Gillen et al. Genome Biology          (2021) 22:284 Page 23 of 31
S11AB). For figures of ribosome position across individual mRNAs, the P-site position
was used (Fig. 6B–D, Additional File 1: Fig.S6).
Ribosome profiling—total RNA alignment and counts
For the corresponding total mRNA samples, cutadapt [128] was used to remove
adapter sequences, cd-hit-dup [129] to deduplicate based on the 8 nt UMI. The UMI
was then removed with cutadapt, and the sequences aligned with STAR [130] to a gtf
file filtered for the most abundant transcript per gene. Bam files were sorted and
indexed using SAMtools [135]. Read counts were obtained using htseq-count [136].
DESeq2 differential expression analysis
DESeq2 [85, 86] was used for differential expression analysis of the RNA and RPFs fol-
lowing CNOT1 knockdown. As the RPFs and RNA are very different library types,
something the DESeq2 package is not able to account for, the differential expression
analysis was conducted independently for the two datasets. The data was pre-filtered to
ensure at least three samples had a minimum of 10 read counts for any given mRNA.
To ensure that lower abundance mRNAs or lowly translated mRNAs do not have an
exaggerated fold change, the lfcShrink function with apeglm model of the DESeq2
package was used for effect size estimations [86]. Log2FC translational efficiency was
calculated as log2FC RPF − log2FC RNA from the DESeq2 results (Additional File 3:
Table S2). DESeq2 was also used in the same manner to determine the log2FC in RNA
in cytosolic and ER fraction following CNOT1 depletion (Additional File 5: Table S4).
Differential ribosome occupancy across the CDS
For the total RNA data, transcripts per million (TPM) was calculated. For the RPFs, the
read data was normalized for library size and for each read the nucleotide of the P-site
start used (12 nt offset from read start). RPF counts at each position along the CDS of
each mRNA were then normalized for the mRNA abundance using the TPM from the
total RNA-seq. After this normalization to account for mRNA abundance changes, for
each biological replicate a delta was conducted for the normalized RPF coverage along
each mRNA between CNOT1 and control siRNA conditions. The delta for each mRNA
was then averaged for the three biological replicates. For Fig. 3E, J, the delta in the dis-
tinct groups of mRNAs was binned into 40 windows across the CDS to account for the
different CDS lengths of the mRNAs and the median change in ribosome occupancy in
each window displayed.
Gene Set Enrichment Analysis
Normalized enrichment scores for biological process, cellular component, and molecu-
lar function gene sets were calculated using the fgsea R package. Significant enrichment
was determined using an adjusted p value threshold of < 0.05. The full list of significant
results is in Additional File 4: Table S3.
Synonymous codon usage
Synonymous codon usage is based on the fact that for many amino acids there are mul-
tiple codons that encode it. For each codon, the number present within a given CDS
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were counted and then normalized for the total number of possible codons that can en-
code the same amino acid in that CDS. This was conducted for each mRNA, and then
for the distinctly regulated groups of mRNAs, this was then averaged across the group.
The heatmaps are column-scaled as the comparison being made is the preferential use
of the codons between the different groups of mRNAs (Fig. 5A). The colored bar indi-
cates the nucleotide at the third position of the codon.
Amino acid usage
For amino acid usage, the frequency of codons for each amino acid were counted per
mRNA and normalized for the number of codons in the mRNA. The frequency for
each amino acid was then averaged across the group of mRNAs (if the amino acid fre-
quency for an mRNA was zero, it was excluded from the average). The heatmaps are
column-scaled as the comparison being made is the use of the amino acid between the
different groups of mRNAs (Fig. 5B). The colored bar indicates the type of amino acid
side chains. For Fig. 5C, D, amino acids were classified as disorder-promoting
(P|Q|E|S|K) as in [106].
Ribosome pause site determination
For analysis of paused elongating ribosomes, all RPFs apart from those located in the
first 15 and last 5 codons of the CDS were used. A pause site in each condition was de-
fined as a position with a RPF peak height ten times greater than the average RPF peak
on the mRNA. The change in peak height between conditions was determined as a
delta between RPFs that had been normalized for the mRNA abundance (TPM). Pause
sites were then classified as either “sustained” if there was no change in peak height;
“resolved” if RPF peak height decrease was ten times greater than the average delta de-
crease across the mRNA; or “induced” if the increase in RPF peak height was ten times
greater than the average delta increase (Fig. 6A). The mRNAs distinctly with one type
of pause site are used in downstream analysis and the exact pause positions are indi-
cated in Additional File 7: Table S6.
Motif analysis
For the amino acid motifs generated in Fig. 6G–I, the Seq2Logo web app was used
[111]. The settings used were P-Weighted Kullback-Leibler logo type, Hobohm1 clus-
tering method, and 200 weight on prior.
k-means clustering
For clustering of mRNAs based on their half-lives (Fig. 1B) in the presence and absence
of CNOT1, the half-life values were log transformed and the optimal number of clus-
ters determined using within cluster sum of squares. The factoextra R package was
used for k-means analysis and cluster visualization. For clustering of mRNAs into ER-
targeted and cytosolic mRNAs in control conditions (Fig. 3C), the RNA-seq counts
were first transformed into counts per million (CPM) and adjusted using the ERCC
spike-in sequences to account for differences in absolute RNA levels between the cyto-
solic and ER fractions.
Gillen et al. Genome Biology          (2021) 22:284 Page 25 of 31
Statistics
The Kruskal-Wallis test was used for Fig. 3F–I. For all the figures requiring multiple
comparisons, the Dunn test (FSA R package) was used to determine significance and
Benjamini Hochberg method applied to correct for multiple hypothesis testing. For the
groups of mRNAs distinctly regulated by the Ccr4-Not complex as identified in Fig.
4A, the full set of statistical comparisons between the data for each group are included
in tables in Additional File 9 for clarity. *** indicates p.adj < 0.001, ** p.adj < 0.01 & *
p.adj < 0.1. For Additional File 1: Fig S9B, a two-tailed paired t-test was used.
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